A non-invasive method for determining the presence or severity of a bodily disorder associated with hyperactivity or increased expression of a signal transduction protein, transcription factor, or protein kinase that is a member of the MAPK or GPCR pathways. A reagent that binds to such a signal transduction protein, transcription factor, or protein kinase is non-invasively contacted to a tissue or fluid within the body of a subject or to a fluid removed from a subject, the reagent is permitted to bind to the signal transduction protein, transcription factor, or protein kinase in the tissue or fluid, the presence of binding of the reagent to the signal transduction protein, transcription factor, or protein kinase in said tissue or fluid is determined, and the binding is correlated with the presence or severity of said bodily disorder within the subject.
一种非侵入性方法,用于确定是否存在或严重存在与
信号转导蛋白、转录因子或蛋白激酶(属于
MAPK 或
GPCR 通路的成员)活性亢进或表达增加有关的身体失调。将与这种
信号转导蛋白、转录因子或蛋白激酶结合的试剂非侵入性地接触受试者体内的组织或液体,或接触从受试者体内取出的液体,允许试剂与组织或液体中的
信号转导蛋白、转录因子或蛋白激酶结合、测定试剂与所述组织或液体中的
信号转导蛋白、转录因子或蛋白激酶的结合情况,并将结合情况与受试者体内所述身体失调的存在或严重程度相关联。